医学
放射性碘疗法
甲状腺
肝损伤
疾病
内科学
重症监护医学
外科
甲状腺癌
出处
期刊:Int J Radiat Med Nucl Med
日期:2015-11-25
卷期号:39 (6): 483-486
标识
DOI:10.3760/cma.j.issn.1673-4114.2015.06.010
摘要
At present, anti-thyroid drugs, radioactive iodine (131I) and surgical therapy were considered as the three major methods for hyperthyroidism therapy. With the acceptance of the safety of 131I therapy in hyperthyroidism, more and more patients become to choose it as their therapeutic method, especially the patients with liver injury or blood cell reduction complications. This paper summaries the advantages and risks of 131I therapy in this two special hyperthyroidism patients groups according to the recent paper and clinical practice.
Key words:
Graves disease; Hyperthyroidism; Brachytherapy; Liver diseases; Blood cell reduction
科研通智能强力驱动
Strongly Powered by AbleSci AI